What is KOL Management?
KOL Management is the complete life cycle of identifying, profiling and engaging with the right Key Opinion Leaders based on the business objectives.
KOL Management Platform for Life Sciences companies helps them to manage their relationship with KOLs. Key Opinion Leaders or Key Thought Leaders or Key External Experts are Healthcare Professionals (HCPs) who influence their peers in the medical community. Pharmaceutical/Biotechnology companies need a strategic approach and solution to identify, map, profile, engage and interact with the right set of medical experts for various KOL Management and Development activities.
Role of KOL Management for Pharma companies
KOL Management is an ongoing process that needs constant check and validation to ensure that the Key Opinion leaders who are being engaged are the right set of Healthcare Professionals who can create awareness about the product or brand. Pharma companies depend on the collaborations with KOLs for creating a strategic plan and developing drugs that are of utmost need to the patients. This way both Pharma companies and Key Opinion Leaders get benefited mutually.
Key Opinion Leaders are needed for Life Sciences companies at every stage of the drug or device development life cycle. KOLs are engaged by Pharmaceutical companies in multiple roles including advisory boards, consulting activity, Clinical Investigators, Scientific publishers, prolific speakers at Global, National and regional level.
Benefits of KOL Management for Pharma companies
Effective KOL Management plays a critical role for Pharma, Biotech and Medical Device companies in their drug/device development life cycle. Identifying and engaging the right set of Healthcare Professionals directly contributes on drug development and commercial success.
Key Opinion Leader management will continue to evolve as an area that will translate to key interactions in the Life Sciences industry. Every step of the KOL Management process needs to be ensured that it is compliant, mutually beneficial for KOLs and Life Sciences companies, and adds value for the patient journey with the product.
Life Sciences companies who identify, engage and interact with established and emerging Key Opinion Leaders can achieve benefits such as higher visibility, greater reach, and increased profit post-market approval.
Suhas Parashar | 12 July, 2021